KBC Group NV Has $14.45 Million Stake in Mettler-Toledo International Inc. (NYSE:MTD)

KBC Group NV reduced its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 2.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 11,811 shares of the medical instruments supplier’s stock after selling 242 shares during the quarter. KBC Group NV owned approximately 0.06% of Mettler-Toledo International worth $14,453,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in MTD. International Assets Investment Management LLC lifted its position in Mettler-Toledo International by 149,870.0% during the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after acquiring an additional 89,922 shares during the last quarter. Seilern Investment Management Ltd bought a new position in shares of Mettler-Toledo International in the fourth quarter worth about $89,221,000. Canoe Financial LP lifted its position in shares of Mettler-Toledo International by 576.5% during the 4th quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier’s stock worth $67,936,000 after purchasing an additional 47,311 shares during the last quarter. Retirement Systems of Alabama boosted its stake in Mettler-Toledo International by 610.4% during the 3rd quarter. Retirement Systems of Alabama now owns 33,462 shares of the medical instruments supplier’s stock valued at $50,183,000 after purchasing an additional 28,752 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after buying an additional 28,478 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 1.1 %

Shares of MTD opened at $1,338.58 on Thursday. The stock has a 50 day simple moving average of $1,257.26 and a 200-day simple moving average of $1,343.51. The stock has a market cap of $28.24 billion, a PE ratio of 36.09, a PEG ratio of 4.19 and a beta of 1.12. Mettler-Toledo International Inc. has a 1 year low of $1,133.46 and a 1 year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. On average, sell-side analysts forecast that Mettler-Toledo International Inc. will post 40.42 EPS for the current fiscal year.

Analysts Set New Price Targets

MTD has been the subject of several research reports. Stifel Nicolaus reduced their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Robert W. Baird cut their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Wells Fargo & Company decreased their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Finally, Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their price target for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $1,351.25.

Insiders Place Their Bets

In other news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.